E3 Ubiquitin Ligase CHIP Inhibits the Interaction between Hsp90β and MAST1 to Repress Radiation Resistance in Non-Small-Cell Lung Cancer Stem Cells

The radiation resistance of cancer stem cells poses a critical obstacle for management of non-small-cell lung cancer (NSCLC). It is interesting to note that E3 ubiquitin ligase CHIP is involved in radiation resistance and stemness phenotypes in NSCLC, while the downstream mechanisms remain elusive. Therefore, this study is aimed at exploring the possible molecular mechanism of E3 ubiquitin ligase CHIP in radiation resistance of NSCLC stem cells. Cancer and adjacent normal tissues of NSCLC patients were collected to determine expression of CHIP, Hsp90β, and MAST1. CD133+ cells were isolated from the NSCLC tissues and the lung cancer cell line A549 by flow cytometric sorting. Accordingly, downregulated CHIP and upregulated Hsp90β and MAST1 were observed in cancer tissues from NSCLC patients and in NSCLC stem cells. Sphere formation assay, colony formation assay, and flow cytometry were performed to examine self-renewal ability, survival, and apoptosis of NSCLC stem cells. An animal model of tumor xenograft was developed in nude mice to observe the tumorigenic ability and radiation resistance of NSCLC stem cells. CHIP overexpression was demonstrated to inhibit the NSCLC stem cell properties and radiation resistance in vitro and in vivo. Mechanistically, CHIP promoted MAST1 ubiquitination by blocking Hsp90β interaction with MAST1, thus inhibiting MAST1 protein stability. Furthermore, CHIP-mediated downregulation of MAST1 protein stability inhibited the NSCLC stem cell properties and radiation resistance. Collectively, CHIP promotes the ubiquitination of MAST1 by blocking the interaction of Hsp90β with MAST1, leading to decreased MAST1 protein stability, which suppressed NSCLC stem cell properties and radiation resistance.

[1]  Lianhong Pan,et al.  Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. , 2022, Pharmacological research.

[2]  Xu Wang,et al.  Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1 , 2021, Nature Communications.

[3]  Kaitai Zhang,et al.  Elevated expression of lung development-related protein HSP90β indicates poor prognosis in non-small cell lung cancer through affecting the cell cycle and apoptosis , 2021, Signal Transduction and Targeted Therapy.

[4]  W. Qu,et al.  Carboxy terminus of HSP70‐interacting protein (CHIP) attenuates the stemness of thyroid cancer cells through decreasing OCT4 protein stability , 2020, Environmental toxicology.

[5]  Ping Wang,et al.  Overcoming of Radioresistance in Non-small Cell Lung Cancer by microRNA-320a Through HIF1α-Suppression Mediated Methylation of PTEN , 2020, Frontiers in Cell and Developmental Biology.

[6]  T. Yevsa,et al.  Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies , 2020, Frontiers in Immunology.

[7]  Yunfeng Zhou,et al.  UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation. , 2020, Cancer letters.

[8]  S. Vinod,et al.  Radiotherapy treatment for lung cancer: Current status and future directions , 2020, Respirology.

[9]  S. Jang,et al.  Prognostic Significance of CHIP and RIPK3 in Non-Small Cell Lung Cancer , 2020, Cancers.

[10]  Lingqiang Zhang,et al.  Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer , 2020, Cell Death & Differentiation.

[11]  M. Matsumoto,et al.  Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells , 2020, Cells.

[12]  S. Lonial,et al.  Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation. , 2019, The Journal of clinical investigation.

[13]  Jeong-Seok Nam,et al.  The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance , 2019, Journal of Experimental & Clinical Cancer Research.

[14]  Bao-qin Liu,et al.  Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation , 2019, Oncogene.

[15]  E. Sabidó,et al.  The cochaperone CHIP marks Hsp70- and Hsp90-bound substrates for degradation through a very flexible mechanism , 2019, Scientific Reports.

[16]  Jie Gu,et al.  Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex. , 2019, Cancer letters.

[17]  F. Kruyt,et al.  Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting , 2019, Biochemical pharmacology.

[18]  L. Min,et al.  Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer , 2018, BMC Pulmonary Medicine.

[19]  Bentong Yu,et al.  TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1 , 2018, Autophagy.

[20]  F. Khuri,et al.  MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation. , 2018, Cancer cell.

[21]  M. Cobb,et al.  Pulling a MAST1 on Cisplatin Resistance. , 2018, Cancer cell.

[22]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[23]  Thi Hong Van Le,et al.  Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells. , 2018, Cancer letters.

[24]  S. Iqbal,et al.  Therapeutic Uses of HSP90 Inhibitors in Non-Small Cell Lung Carcinoma (NSCLC). , 2018, Current drug metabolism.

[25]  C-Y Chen,et al.  GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug , 2017, Oncogene.

[26]  W. Ge,et al.  Multiple functions of the E3 ubiquitin ligase CHIP in immunity , 2017, International reviews of immunology.

[27]  Ming Yan,et al.  Cancer stem-like cell related protein CD166 degrades through E3 ubiquitin ligase CHIP in head and neck cancer , 2017, Experimental cell research.

[28]  Min Young Kim,et al.  Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation , 2017, Molecular Cancer.

[29]  Wang Qingfeng,et al.  CHIP involves in non-small cell lung cancer prognosis through VEGF pathway. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  H. Shukla,et al.  Caveolin-1: a novel prognostic biomarker of radioresistance in cancer , 2016, International journal of radiation biology.

[31]  H. Abrahamse,et al.  The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. , 2016, Journal of photochemistry and photobiology. B, Biology.

[32]  Takeshi Nagayasu,et al.  Germline mutations causing familial lung cancer , 2015, Journal of Human Genetics.

[33]  Eun Hee Lee,et al.  High‐level expression of Hsp90β is associated with poor survival in resectable non‐small‐cell lung cancer patients , 2015, Histopathology.

[34]  J. Soh,et al.  Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors. , 2015, Oncology reports.

[35]  A. Edkins.  CHIP: a co-chaperone for degradation by the proteasome. , 2015, Sub-cellular biochemistry.

[36]  K. Kimura,et al.  Ubiquitin ligase CHIP suppresses cancer stem cell properties in a population of breast cancer cells. , 2014, Biochemical and biophysical research communications.

[37]  P. Drew,et al.  Differential proteomics in the search for biomarkers of radiotherapy resistance , 2011, Expert review of proteomics.